Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Interstitial drug delivery to brain tumours

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.02.16
Views: 1440
Rating:

Dr Henry Brem - Johns Hopkins University, Baltimore, USA

Dr Brem talks to ecancertv at Children with Cancer UK’s workshop on Drug Delivery in Paediatric Brain Tumours in London, UK.

He discusses the use of interstitial drug delivery systems to target brain tumours.

Dr Brem highlights how the combination of chemotherapy wafer implants, radiation therapy and oral temozolomide have already helped increase the survival of patients with glioma substantially from 9 to 21 months.

The use of immunotherapies such as checkpoint inhibitors with local delivery of chemotherapy is potentially very promising.

Related videos

18.10.18

no rating
For HSCT in Ph-positive ALL

follow us

War on Cancer 2018


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation